Clinical trial
Cessation of Biologic Treatment in Patients With Takayasu Arteritis in Sustained Remission
NCT07491913 is registered in ClinicalTrials.gov with Marmara University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cessation of Biologic Treatment in Patients With Takayasu Arteritis in Sustained Remission
- Lead sponsor
- Marmara University
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 15, 2025
- Completion date
- December 15, 2027
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.